Vimarsana
Biggest News Aggregation in the World

Raanan Berger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Raanan Berger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Raanan Berger Today - Breaking & Trending Today

Cornerstone laid for Shira and Ishay Davidi oncology center at Sheba - Vimarsana News

Cornerstone laid for Shira and Ishay Davidi oncology center at Sheba

The cornerstone laying ceremony for the Shira and Ishay David Center for Urgent Oncology Medicine at Sheba Medical Center took place February 4, the day International Cancer Day was marked.

Source: jpost.com
Nectin Therapeutics Advances Ongoing Clinical Trial and Expands Sites to Israel - Vimarsana News

Nectin Therapeutics Advances Ongoing Clinical Trial and Expands Sites to Israel

/PRNewswire/ -- Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved...

Belong.Life launches AI SaaS to match cancer patients to trials - Vimarsana News

Belong.Life launches AI SaaS to match cancer patients to trials

Built upon seven years of real-world patient journey data, Belong.Life has recently announced the launch of its software as a service (SaaS)-based conversational artificial intelligence (AI) cancer clinical trial matching platform.

MEDIA ADVISORY: Media Workshop: Understanding Cancer In Sub-Saharan Africa - Vimarsana News

MEDIA ADVISORY: Media Workshop: Understanding Cancer In Sub-Saharan Africa

JOHANNESBURG, South Africa, 14 July 2022/ African Media Agency (AMA)/- On behalf of a leading global biopharmaceutical company, MSD, we invite you to attend a

Source: africa.com
Israeli company debuts multi-cancer response predictor - Vimarsana News

Israeli company debuts multi-cancer response predictor

Pangea Biomed Launches Multi-Cancer Response Predictor, Increasing cancer Patient Benefits from Precision Oncology by 5x.

Source: jpost.com